Organisation Category
Business Consultancy Organisation

Services
Business Consultancy Services  

biostate provides consulting services to those individuals, institutions and commercial entities who require assistance to identify and realise the commercial potential of their research. With significant experience in the health sector, and as active participants in the biotech and pharmaceutical forums, we can provide:

• advice in identifying the commercial potential of an idea or technology
• assistance in the development of business and marketing plans
• representation for our clients in relevant meetings, conferences or other forums
• guidance in the identification and selection of strategic partners
• support in negotiation of commercial and licensing agreements
• introductions to industry contacts.

read more...

Organisation Category
Corporate Advisory 
Financial Planning
Stockbroking 

Services
Investment consultancy service
Research of listed life science companies

Therapy Area Experience
Devices  
Oncology  
Pain  

The trusted RBS Morgans team of corporate finance professionals are market leaders in all aspects of corporate finance solutions, with a demonstrated track record of delivering outcomes for Australian small and mid-cap companies. Housing a number of world class corporate finance advisers and analysts who specialise in the health care and biotech sector, RBS Morgans has the expertise to guide companies through the capital raising process.

We offer a full range of corporate finance, equity capital markets and advisory services including:

• Initial public offers
• Secondary raisings – placements, rights issues, share purchase plans
• Hybrid and convertible offers
• Share buy backs
• Merger and acquisition advisory – relating to the assessment of acquisitions, mergers, joint ventures and divestment opportunities
• Takeover defence
• Asset / business sales
• Private equity / venture capital

Since the early 1990’s our team at RBS Morgans has structured and raised more than $16.5 billion in new capital for clients in over 950 transactions. We provide our clients with direct access to retail equity markets (through a national stockbroking network), domestic institutional investors (through our dedicated small-mid cap institutional sales team) and international institutional clients (through the Royal Bank of Scotland international network).

read more...

Organisation Category
Manufacturing Facility/Contract Manufacturing Organisation

Services
Bioprocessing/Fermentation  
Contract Manufacturing/Scale-up 
Formulation & Fill 
Process Development 
Tissue Banking 

Therapy Area Experience
Manufacture of a range of therapeutics

BPA has been established with the support of the Queensland Government to achieve two broad objectives:

• To design, fund and implement construction of a biotherapeutic manufacturing facility to be operated in alliance with an experienced international partner
• To support and grow existing local Australian biotherapeutic manufacturing organisations, and to facilitate synergies between complementary providers of clinical development services.
• The new facility with provide a service solution for companies with biological drug candidate who seek to outsource their process development and manufacturing.  It will provide cutting-edge technical and economical methods for generating biopharmaceutical compounds expressed in mammalian cells.

The facility will enable early stage research to be converted into robust, production-ready processes, which can be tested at pilot scale before moving into the highly controlled GMP manufacturing environment required for human medicinal products. BPA will not only cater for pre-clinical development projects, but also for clients manufacturing for clinical trials and the marketplace.

Due to be opened in early 2013, the facility upstream suites will cater for mammalian cell culture up to 2000 litres, with the ability to accommodate future expansion.

Organisation Category
Government – State 
Public Hospital 

Services
Analytical/Pathology Laboratory Services
Clinical Data Management Patient Recruitment
Clinical Monitoring Patient Screening
Clinical Research Treatment of Subjects (Phase III/IV Trials)
Paediatric Clinical Trials 

Therapy Area Experience
Anaesthesilogy 
Cardiology 
Cardiovascular 
Endocrinology 
Gastroenterology 
General Medicine 
Geriatric Medicine  
Obstetrics 
Orthopaedics 
Paediatrics 
Physiotherapy 
Psychiatry 
Radiology
Renal Medicine
Respiratory/Pulmonary
Stroke
Surgery
Urology

General acute outer metropolitan hospital with a busy emergency department, obstetric service, paediatrics, medicine, cardiology, surgery and mental health departments. The Redland Hospital is collocated with a private hospital as well as a residential nursing facility.

Organisation Category
On-line Matching Service

Services
Lab and Consultant Options 
On-line Matching Services

Therapy Area Experience
Allergy
Anti-infectious
Autoimmune Disease
Cardiology
Cardiovascular
CNS/Neurology
Complementary  Medicines
Dermatology
Devices
Endocrinology
Gastroenterology
Genitourinary
Geriatric Medicine
Haematology 
Hypertension
Immunology
Infectious Diseases
Lymphoma
Migraine
Multiple Areas
Multiple Sclerosis
Neurogenetic Disorders
Nutraceutical
Obstetrics
Oncology
Ophthalmology
Orthopaedics
Osteoporosis
Paediatrics
Pain
Pathology
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Rheumatology
Stem Cell Research
Stroke
Surgery
Transplantation
Urology
Vaccines

BioAssayLINK is the ‘Wotif’ or ‘Expedia’ of global therapeutic R&D expertise and capabilities. Our online linking tool connects industry with the expertise and capabilities that they need to advance their new therapeutics. BioAssayLINK is the first convenient online marketplace of biomedical researchers, service providers and specialised consultants. The linking tool provides a rapid, cost effective and customer-specific way for seekers to connect with specialised providers. Seekers submit (and soon search) their laboratory and/or consultant options online. Providers are charged a nominal annual fee to list their specific capabilities and expertise. BioAssayLINK is headquartered in Brisbane, Australia, with distribution networks and affiliates in the United States of America and the United Kingdom and is constantly expanding.

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Services
Clinical Research 
Medical Research 

Therapy Area Experience
Endocrinology 

The Endocrine Clinical Trials Network is based in one of the largest public hospitals in Australia and has been participating in clinical trials since 1986. It has a long history of successful recruitment into clinical trials due to the large patient population that it draws on. Its principal investigator, Dr Michael d’Emden has been on the management committee of several major international trials such as ASPEN, FIELD and TNT. It delivers high quality data and has received high commendations after many major audits. Its major clinical focus is any endocrine study, especially in diabetes and cardiovascular disease prevention trials.
 

Organisation Category
Analytical/Pathology Laboratory 
Central Laboratory 
Clinical Research Organisation 
Contract Research Organisation 
Dedicated Clinical Trials Centre (as part of a public or private hospital
Medical Department
Research Organisation

Services
Clinical Research 
Medical Research 
Pharmacokinetic Analysis 
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience
Allergy  
Anti-infectious  
Cardiovascular  
CNS/Neurology  
Dermatology  
Endocrinology  
Gastroenterology  
Genitourinary  
Haematology
Immunology
Men’s Health
Otolaryngology
Paediatrics
Pain
Psychiatry
Renal Medicine
Respiratory/Pulmonary
Rheumatology
Urology
Vaccines
Volunteers
Women’s Health

AusTrials, a wholly-owned subsidiary of Primary Health Care Ltd, is a leading provider of high-quality clinical research site services in Australia, conducting Phase II to IV studies in a wide range of therapeutic areas.
AusTrials builds on proficiency and expertise gained through the Australian Clinical Research Organisation (ACRO), with over 20 years of successfully conducted studies in over 50 therapeutic areas. The clinical research group has grown to seven cetnre in three states, with over 40 staff.  AusTrials is recognised for prompt study start-up and the highest standards in clinical research data.  AusTrials has also established GP Trial sites in a number of Primary medical centres, with new sites in development. Clinical trial coordinators are engaged on a permanent basis at GP Trials sites, improving recruitment across all Phase II-IV clinical trials.
AusTrials has working relationships with specialists in areas such as Neurology, Cardiology, Respiratory Medicine, Diabetes and Gastroenterology; and is able to communicate with over 1000 General Practitioners in large-scale, well-equipped medical centres throughout most states; with access to Pathology, Radiology, and Health Information technology.

Organisation Category
Biotech Consultancy Organisation 
Business Consultancy Oragnisation 
Government Liaison
Marketing & Communications Company

Services
Biotech Consultancy Services 
Business Consultancy Services 
Commercialisation Services 
Investment Consultancy Services 
Market Research
Marketing & Communications Services

Providing specialist services:
• Government Liaison
• Infrastructure Development Consultant
• Policy Development Advisor
• Networking and Connection Facilitator
• Board Representation
• Corporate Risk Consulting
• Aged Care Consulting Services
• Business Development
 

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital) 
Medical Research Institute 
Not-for-profit Institution/Organisation
Research Institution

Services
Biostatistical Analysis 
Clinical Data Management 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration
Clinical Trial Management & Logistics
Clinical Trial Site Services
Literature Reviews
Medical Research

Therapy Area Experience
Cardio-electrophysiology 
Cardiology 
Cardiovascular
CNS/Neurology
Orthopaedics

St Andrew’s Medical Institute (SAMI) supports clinical trial activities undertaken by the leading medical specialists at St Andrew’s War Memorial Hospital in Brisbane.  These specialists treat a procedural and medical casemix which is among the most acute in Australia, with substantial volume in specific therapeutic areas. SAMI’s collaborative arrangements with St Andrew’s Hospital enable direct access to the technology and facility infrastructure to support these activities.

Organisation Category
Analytical/Pathology Laboratory 
Biomarker Discovery 
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Medical Research Institute 
Not-for-profit Institution/Organisation 
Preclinical Facility
Research Institution
Research Organisation

Services
Analytical/Pathology Laboratory Services
Bioassays 
Bioinformatics 
Biomarkers Discovery 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration 
Contract Research Services 
Genomics Research 
Medical Research 
Nutraceutical
Patient Recruitment
Pharmacogenomics
Preclinical Research
Tissue Banking
Translational Medicine
Treatment of Subjects (Phase 0 Trials)
Treatment of Subjects (Phase I/II Trials)
Treatment of Subjects (Phase III/IV Trials)

Therapy Area Experience
Endocrinology 
Men’s Health 
Nutraceutical 
Oncology  
Pathology 
Surgery 
Urology

The Australian Prostate Cancer Research Centre – Queensland is a transdisciplinary research centre focussed on the development of prostate cancer therapeutics and prognostic biomarkers. Hosted by the Queensland University of Technology at the Princess Alexandra Hospital, the APCRC-Q’s activities span from high throughput discovery, molecular pathology and functional characterisation of potential targets, through to preclinical therapeutic development and evaluation and clinical trials. The APCRC-Q is underpinning the establishment of a multi-disciplinary prostate cancer clinical trials unit at the Princess Alexandra Hospital for Phase I/II and III trials.

The prostate cancer clinical trials unit will work in close association with the Australia New Zealand Urogenital and Prostate Cancer Clinical trials consortium and the Trans-Tasman Radiation Oncology Group, as well as the international prostate cancer-focussed clinical trials consortia.  The APCRC-Q is the Australian hub of the Australian-Canadian Prostate Cancer Research Alliance Program.  This international network partners more than 250 scientists, clinicians, and other professionals working in prostate cancer, in order to facilitate access to unique resources, leading edge infrastructure, and clinical trials networks. The Australian Prostate Cancer Research Centre – Queensland is highly interested in working collaboratively or contracting with biotech, pharma and other industries in the development of new therapeutics, imaging and biomarkers.

Organisation Category
Medical Cooperative Group 
Not-for-Profit Public Benevolent Institution

Services
Clinical Trial Administration  
Ethics Committee 
Protocol Review & Amendment Service
Ethics Committee Expedited Access for Submissions

Therapy Area Experience
Oncology 
Radiology 
Respiratory/Pulmonary  
Transplantation 
Vaccines
Volunteers 

The Australian Lung Foundation’s Multi-Centre Clinical Trials Network (ALF MCTN) is an established service available to clinical trial sponsors and Clinical Research Organisations (CROs).  It provides access to a large-scale investigator and patient database.  The MCTN is supported by an efficient ethics submission process as well as an established network and recruitment management system.
The Network has been formed to support both local and international studies. It does not compete with the institutions that currently undertake clinical trials, but will enhance the recruitment base so that collectively, recruitment targets and tight study timelines can be met.  The ALF MCTN business returns any surplus earned to the ALF assisting the Foundation to fulfill their vision as a key agent of change in Australia, bringing about the understanding, management and relief of lung disease.

Organisation Category
Analytical/Pathology Laboratory 
Central Laboratory

Services
Analytical/Pathology Laboratory Services
Clinical Trial Management & Logistics 
Logistics 

Therapy Area Experience
All areas   

Sullivan Nicolaides Pathology has considerable experience in the provision of clinical trial services to the pharmaceutical industry and university research departments.
Logistics: Whilst utilising the extensive coverage of our own courier network, Sullivan Nicolaides Pathology also works in close co-operation with major courier companies to supply investigator sites with supplies, and rapid pick-up and return of samples for testing.
Rapid Result Turnaround: Sullivan Nicolaides Pathology provides services 24 hours a day, 7 days a week.  All samples are processed immediately on arrival with most reports being returned to the investigator site within 24 hours by transmission medium of your choice.
Supplies and Documentation: Collection supplies can be supplied as visit-specific kits or in ‘bulk.’ Request forms are study and site specific. Comprehensive, easy to use laboratory manuals are provided for each investigator site to ensure good site compliance.
Trials Management: Sullivan Nicolaides Pathology has dedicated in-house staff assigned to assist investigators in providing the samples required and to ensure that all requisitions are complete.
 

Organisation Category
Analytical/Pathology Laboratory 
Bioanalytical Facility 
Contract Research Organisation
Preclinical Facility

Services
Analytical/Pathology Laboratory Services 
Bioassays 
Efficacy- in-vitro and in-vivo models of efficacy 
Toxicology: in-vitro and in-vivo, genotoxicity assays, dose-range finding studies
Pharmaceutics: characterisation, stability, formulation development, dissolution
Pharmacokinetic Analysis
Pharmaceuticals & Toxicology
Translational Medicine

Therapy Area Experience
Allergy  
Anaesthesiology 
Autoimmune Disease 
Cardiovascular  
CNS/Neurology 
Complementary Medicines 
Dermatology
Endocrinology 
Gastroenterology 
Multiple Sclerosis
Nutraceutical 
Paediatrics 
Pain
Psychiatry
Respiratory/Pulmonary
Rheumatology
Vaccines

TetraQ is Australia’s leading, fully-integrated preclinical drug development contract research organisation (CRO) providing a range of high-quality, integrated and tailored preclinical services (ADME, Efficacy, Pharmaceutics, Toxicology) globally to pharmaceutical and biotechnology industries.  TetraQ has NATA ISO 17025 (R&D) accreditation and GLP recognition which allows bioanalytical and toxicology work to be accepted internationally for regulatory review and provides a high degree of assurance for TetraQ clients.
TetraQ work with companies developing new drugs, seeking assistance with selecting a drug candidate or requiring preclinical drug characterisation. TetraQ develop preclinical programs to ensure careful selection of studies which is critical to save on time and expenditure.
TetraQ aims to provide a ‘one-stop’ service and advice for clients. TetraQ has world-class facilities backed by a highly-skilled scientific team with a wealth of experience in all four core disciplines of preclinical development. The TetraQ team take the time to understand your business needs and provide comprehensive tailored solutions either in-house or through their extensive network. In addition to providing a range of contract services, TetraQ can also:
• Consult to your business by providing expert opinions, reviewing and interpreting data, reviewing and preparing product development plans and assisting in due diligence.
• Advise on early-stage drug development activities including regulatory strategy.
TetraQ currently provide services to clients base in the United States of America, Japan, Europe, the United Kingdom, SE Asia and New Zealand.

Organisation Category
Commercialisation Company

Services
Commercialisation Project Management Services
Market Research and Opportunity Analysis
Professional Development Programs to increase Commercialisation skills and successes
Strategic Advice around Intellectual Property Management and Commercialisation
Technology Transfer Facilitation and brokerage of Intellectual Property (IP)

The Australian Institute for Commercialisation (AIC) is a leading service organisation helping innovators achieve commercial success. Around Australia, the AIC helps business, research organisations and governments convert their ideas into successful outcomes.
Using our networks and experience, we deliver services that facilitate collaboration, enhance innovation and accelerate the commercialisation of know-how and technology that our clients have created.
By providing advice, solutions and tools, and through our intermediary services, we fast-track the commercialisation of Australian innovation.
Clients working with the AIC are able to better develop their ideas and capitalise on opportunities that create high value jobs, exports and wealth.
 

Organisation Category
Research Institution 

Services
Bioassays 
Bioprocessing/Fermentation 
Commercialisation Services 
Contract Research Services Diagnostic Development & Delivery 
Drug Delivery
Drug Discovery
Preclinical Research
Training

The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) is an integrated multi-disciplinary research institute bringing together the skills of world-class researchers in the areas of bioengineering and nanotechnology.
It is home to 18 research groups working at the interface of the biological, chemical and physical science to alleviate current problems in human health and environmental issues.
The Institute has three key areas that collectively distinguish it from other institutes in the country, namely AIBN’s:
• Research Excellence;
• Industry Focus; and
• Dynamic Research Environment

These characteristics focus AIBN research efforts on developing new products, processes and devices for improving human health and quality of life. In this way the Institute goes beyond basic research to promote and develop the growth of innovative industries, which will benefit the Queensland and Australian economies.
 

Organisation Category
Clinical Research Organisation 
Clinical Trials Unit

Services
Clinical Research  
Clinical Research Network Contract Research Services 
Medical Research
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience
Allergy
Anti-infectious
Cardiovascular
CNS/Neurology
Complementary Medicines
Devices
Endocrinology
Gastroenterology
General Medicine
Genitourinary
Geriatric Medicine
Hypertension
Immunology
Infectious Diseases
Men’s Health
Migraine
Multiple Areas
Nutraceutical
Osteoporosis
Paediatrics
Pain
Respiratory/Pulmonary
Vaccines
Volunteers
Women’s Health

Trialworks is a community-based clinical trials centre with access to a large GP network and healthy volunteers.  The PI has had 15 years experience in Phase II-IV clinical trials and outcomes-based studies across a wide range of indications in both public and private settings.  Trials have been conducted for all the major pharmaceutical companies, CROs and University-based research centres. The centre is staffed by highly experienced research nurses/trial coordinators who have been working with the PI for more than nine years. Trialworks works closely with both public and private institutions to ensure the successful conduct and completion of its contracted trials.

Organisation Category
Contract Research Organisation 
Genomics Service Provider to Academic and Industrial Markets
Not-for-profit Institution/Organisation

Services
Bioinformatics 
Clinical Research
Contract Genomics Services 
Genomics Research  
Medical Research
Pharmacogenetics
Pharmacogenomics
Provision of Genomics Services to industrial customers for applied applications such as Microbial Identification, quality screening as part of biopharmaceutical production
Quality Assurance

Australian Genome Research Facility Ltd (AGRF) was established in 1997 with the mission of providing high quality genomic services to the academic and industrial markets spanning biomedicine, plant and animal science, microbiology, evolutionary biology and biodiversity.
With facilities in Brisbane, Melbourne, Adelaide and Sydney, AGRF Ltd is Australia’s largest genomics service provider. We place a high valued on quality and maintain accreditation to the internationally recognised ISO 17025:2005 quality standard as well as other regulatory licences. The AGRF Brisbane Node houses AGRF’s Sanger and Next-Generation sequencing services as well as the Sequenom SNP Genotyping platforms. AGRF’s services range from pharmacogenomics, small to large-scale DNA sequencing using Sanger and Next-Generation technologies, genotyping/SNP analysis, gene expression studies and small to large scale nucleic acid extractions. Our services are underpinned by the provision of customised bioinformatics solutions.
 

Organisation Category
Not-for-profit institution/organisation

Services
Business Consultancy Services

TropLinks Inc. is the engine that will power the research, development and export of Australia’s tropical expertise to the world.  Its primary goal is to develop a globally competitive tropical economy by establishing Australia as a world leader in tropical science, knowledge and innovation.
As a not-for-profit incorporated association, TropLinks Inc. is a network of research bodies, companies, industry groups and economic development organisations that are working together to build the critical mass needed to capture a slice of the global tropical market.  Within the network, members maintain their own corporate identity and benefit from the synergy of association and complementary skill sets that TropLinks Inc. offers.
TropLinks Inc. provides the branding, support and vision that members need to expand their tropical reach without sacrificing corporate identity or IP ownership. It provides the following services to members:
• Funding and capital raising – actively identifying funding pools and attracting investment for projects and industry development.
• Business matching – bringing members together to bid collaboratively for major projects.
• Identity and branding – creating a united, internationally-recognised presence to make it easier for members to market products and services.  TropLinks Inc. will also focus on establishing a defined industry sector in tropical expertise.
• Stakeholder engagement – networking members and building the critical mass to grow a sophisticated tropical expertise industry.
• Corporate leadership – lobbying, coordinating and securing strategic opportunities for members.

Organisation Category
Biotech Company 

Services
Companion Diagnostics 
Continuous Patient Monitoring 
Molecular Diagnostics
Personalised Medicine
Theranostics

Therapy Area Experience
Devices   
Emergency     
Immunology
Infectious Diseases
Intensive Care
Oncology
Sepsis

Organisation Description

Athlomics’ business is the personalised management of sepsis patients. The incidence of sepsis and septic shock is rising, now affecting younger patients. With a mortality rate of almost 30%, sepsis is the most common non-coronary cause of death in Intensive Care Units.  All-cause sepsis affects 750,000 US hospitalisations yearly and more than half of these are estimated to be hospital-acquired. Sepsis affects 5 to 10% of all hospital patients, leading to an increase of about US$5bn in US health care costs annually. The Total annual cost of sepsis to the US healthcare system is ~US$16bn. Globally, there are an estimate 18 million cases of sepsis per year.

Athlomics’ SeptiCyte® molecular technology can be used for:
1. Earlier detection (<3hrs) and more specific diagnosis of sepsis (85 to 95%; p<0.01), and
2. Regular patient monitoring of
• Sepsis patients in Intensive Care Units (ICU) (immune system response to therapy), and
• Immuno-compromoised patients, e.g. chemotherapy, transplant, AIDS, long-term steroid use, young and the elderly (earlier detection and potential prevention)

Athlomics will launch its first early diagnostic product in Australia in Q2 2010 through Mater Pathology, a wholly-owned business unit of Mater Misericodiae Health Services Brisbane Ltd, Australia.
It has two longitudinal trials underway at Australian hospitals where clinical efficacy is being further evaluated in the regular monitoring of two patient groups:
1. Patients diagnosed with sever sepsis (+ve micro) to monitor the patient’s immune response to therapy, and
2. Patients on chemotherapy (compromised immune system) to monitor for the earlier detection of sepsis.

Athlomics has currently fulfilled Australian regulatory requirements as an LDT.  In the US, the early diagnostic will likely be deemed and In Vitro Diagnostic Mulitvariate Index Assay (IVDMIA) – either Class II or III risk.

Organisation Category
Clinical Trials Unit 
Medical Research Institute 
Not-for-profit Institution/Organisation

Services
Biomarkers Discovery 
Clinical Research 
Clinical Research Network 
Medical Research 
Patient Recruitment 
Preclinical Research 
Tissue Banking
Translational Medicine
Treatment of Subjects (Context of Phase 0 Trials)
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience
Anti-infectious
Cardio-electrophysiology
Cardiovascular
CNS/Neurology
Dermatology
Genitourinary
Infectious Diseases
Intensive Care
Men's Health
Multiple Sclerosis
Neurogenetic Disorders
Nutraceutical
Obstetrics
Paediatrics
Pathology
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Rheumatology
Stem Cell Research
Stroke
Urology
Women's Health

Organisation Description
The University of Queensland’s Centre for Clinical Research (UQCCR) is a new $66M facility designed to bridge the gap between exponentially-expanding biomedical science and the increasing complexity of modern patient care. Our joint ‘bench to bedside’ and ‘bedside to bench’ focus addresses a critical area of unmet need in the early 21st century. UQCCR offers a unique and exciting opportunity for new and established investigations to pursue cutting-edge, clinically-relevant research in a world-class facility.  UQCCR is pivotally located alongside Australia’s largest 1,000 bed tertiary Royal Brisbane & Women’s Hospital (RBWH). UQCCR’s 8,000m2 building boasts state-of-the-art equipment, 1 clinical research floor with outpatient facility for up to 500 patients/day, and 5 wet laboratory floors. Our goals are to foster innovation in clinical research; translate basic and applied research into more effective outcomes for patients; and train tomorrow’s generation of translational researchers and MD PhD Clinical Scientists.

 

Organisation Category
Clinical Research Organisation 
Complementary/Nutraceutical Company 
Contract Research Organisation 
Regulatory Consultancy
Research Organisation

Services
Clinical Monitoring 
Clinical Project Management 
Clinical Research 
Clinical Trial Administration 
Contract Research Services 
Literature Reviews  
Nutraceutical 
Patient Screening
Product Development Strategy
Product Listing & Registration
Protocol Review & Amendment Services
Regulatory Consultancy
Training
Treatment of Subjects (Context of III/IV Trials)

Therapy Area Experience
Complementary Medicines   
Nutraceutical   

Applied Science and Nutrition Pty Ltd (ASN) is an independent Contract Research Organisation specialising in complementary medicine and nutraceutical product research.  We partner closely with our clients to help them develop their ‘ideas’ into successful globally-marketed complementary medicines.  Our primary focus is the design and management of all stages of clinical trials.
ASN comprises a team of regarded specialist complementary medicine researchers that are driven to advance the valid evidence-base for complementary medicines within the broader healthcare context. In collaboration with general practitioners, clinicians and leading service providers, we are uniquely positioned to provide quality complementary medicine research.  Our extensive regulatory knowledge and understanding of the challenges unique to complementary medicine research ensures we are able to design and manage trials that support clients’ product-realisation efforts.

Organisation Category
Biotech Consultancy Organisation 
Business Consultancy Organisation 

Services
Biotech Consultancy Services 
Business Cases for R&D Funding 
Business Consultancy Services 
Commercialisation Services
Investment Consultancy Services
Medical Writing

Therapy Area Experience
Anti-infectious   
Autoimmune Disease  
Cardiology  
Complementary Medicines  
Devices
Infectious Diseases
Nutraceutical
Obstetrics
Oncology
Ophthalmology
Orthopaedics

VenturePro is a professional services firm that specialises in developing and assessing business plans and grant applications for public and private organisations. We have expertise in co-ordinating the development of research project plans, writing business cases for major R&D funding and preparing business plans.  Since 2005, VenturePro clients have been awarded over $280m in government and private funding for R&D projects.  The success rate across all of our clients is 82% with the median grant being $2.0m, and the average being $6.4m. We contribute to science and innovation policy through the development of major life sciences industry analyses including the 2007 and 2009 Queensland Life Sciences Industry Reports. Our clients include universities across Australia including 7 of the G8 Universities, the ATN universities and many others. Some of our health sector clients in Queensland include the Royal Brisbane and Women’s Hospital, Greenslopes Private Hospital, St Andrew’s Medical Research Institute, the Hear and Say Centre, Queensland Brain Institute, TetraQ, QUT Institute of Health and Biomedical Innovation, Queensland Institute of Medical Research, Queensland Tropical Health Alliance, Australian Institute for Bioengineering and Nanotechnology and several biotechnology and medical device companies.

Organisation Category
Business Consultancy Organisation

Services
Biostatistical Analysis 
PGx data interpretation 
PGx reporting and compliance
Pharmacogenomics

Organisation Description
ACTG possesses a unique capability in integrating leading edge molecular, statistical and IT skills across the spectrum of pharmacogenetic/pharmacogenomic activities. It provides these capabilities through:

1. Microarray Design
• Design and content of PGx-specific microarrays
• Detailed technical knowledge of genomic and genetic platforms, including proven experience of the quality control and statistical process control procedures required to manage genetic and genomic data to highest world standards.

2. Study Setup
• Sophisticated experimental design capability, ranging from individual study design through to development and optimization of marker discovery strategy.

3. Study Infrastructure
• Development, management and integration of FDA-compliant information systems for clinical and laboratory data.
• Implementation of fully compliant standard operating procedures and processes, to ensure delivery of high quality data with maximum operating efficiency.

4. Study Execution and Analysis
• Expert biostatistics and bioinformatics linking clinical outcomes to genomics and genetic markers
• Sophisticated analysis of large-scale pharmacogenetic data, with current capability embracing hundreds of thousands of SNPs on hundreds of thousands of patients.

Organisation Category
Business Consultancy Organisation

Services
Business Consultancy Services

Organisation Description
The Principal and Founder of Vicibio, Dr Peter Riddles, has broad experience in science and innovation having contributed to both government and private sector activities in the life sciences industries in Australia and elsewhere.
Vicibio facilitiates strategic planning in organisations where science, technology and innovation are vital to the business activities.
Key clients include governments, public sector research agencies and private sector new ventures. During the facilitation, Vicibio will consider innovation, governance, policy and strategy.
If required, Vicibio will assist the organisation in attracting boards and financing.

Vicibio provides the following core capabilities and experiences:
• Knowledge of innovation policy and strategy
• Experienced Entrepreneur and Director of new ventures
• Experienced Chairman of government and private sector organisation including complex multi-stakeholder ventures
• The ability to conceptualise and develop scoping studies with complex technical and market opportunities
• Experienced at reviewing and evaluating programs in both government and private sector
• Expertise in science and technology and its commercialisation.

The principal of Vicibio, Dr Peter Riddles, may be retained in the longer term as a Chairman/Director or as a strategic advisor, or engaged on a project basis.

Organisation Category
Clinical Research Organisation 
Clinical Trials Unit 
Medical Cooperative Group 
Not-for-profit Institution/Organisation
Research Organisation
Tissue Bank

Services
Bioinformatics 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration 
Contract Research Services 
Tissue Banking
Training
Translational Medicine
Treatment of Subjects (Phase I/II)
Treatment of Subjects (Phase III/IV)

Therapy Area Experience
Genitourinary  
Men’s Health  
Oncology  
Pathology
Psychiatry
Renal Medicine
Urogenital
Urology
Women’s Health

ANZUP is The Australian and New Zealand Urogenital and Prostate Cancer Trials Group funded by Cancer Australia to develop and conduct cancer research in Urogenital and Prostate Cancers. The group fosters collaboration between researchers by aiming to minimise the effect of prostate and other urogenital cancers on the community in terms of survival, incidence and quality of life, through research and education and by providing patients and carers with support and will conduct and promote cooperative clinical trials and psychosocial research and prostate and other urogenital cancers.

The object of the company is to develop, foster and promote prostate and urogenital cancer research by:
• Providing access to clinical trials for all appropriate Australian and New Zealand patients
• Increasing involvement of and collaboration with various professional disciplines in clinical and preclinical research
• Building systems to simplify and streamline clinical research of the highest quality
• Fostering a culture of research amongst all clinicians involved in the care of patients with urogenital cancers
• Providing training opportunities for the next generation of clinical researchers
• Providing for translational studies in prostate and other urogenital cancers, including tissue banking from clinical trials for further studies

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital) 
Medical Research Institute 
Research Institution 
Study Management Organisation
Tissue Bank

Services
Clinical Data Management  
Clinical Monitoring  
Clinical Project Management  
Clinical Research  
Clinical Trial Administration  
Clinical Trial Management & Logistics   
Clinical Trial Site Services
Patient Recruitment
Patient Screening
Project Management Services
Tissue Banking
Translational Medicine
Treatment of Subjects (Phase I/II Trials)
Treatment of Subjects (Phase III/IV Trials)

Therapy Area Experience
Anti-Infectious
Auto-Immune Disease
Cardiovascular
Dermatology
Devices
Endocrinology
Gastroenterology
Gynaecology
Haematology
Healthy Volunteers
Immunology
Intensive Care
Men’s Health
Neurology
Nutraceuticals
Oncology
Pain Management
Psychiatry
Renal Medicine
Rheumatology
Surgery
Urology
Vaccines
Women’s Health

The Wesley Research Institute (WRI), established in 1994, is an independent not-for-profit medical research facility  that provides support for laboratory, clinical and translational research that works towards its shared value of ‘making a difference today.’ The Institute incorporates Queensland’s largest Tissue Bank, an innovative Health and Medical Research Centre and the Clinical Trials Centre. WRI has strong affiliations with world class, research-focused universities and other medical institutes.
The Clinical Trials Centre has an established base of specialist investigators, access to a general practitioner referral network and private hospital services which provides our clients with wide-ranging clinical expertise and a comprehensive, high-quality service which includes:
• Conduct of clinical trials from Phase I-IV (including device and surgical) over a diverse range of therapeutic specialties
• Single point of contact to coordinate single and multi-centre trials
• Timely and cost-effective submission of protocols to the on-site Human Research Ethics Committee
• Efficient financial and contract administration processes
• Specimen collection and management including access to on-site facilities and equipment
• Investigational Product storage & dispensing including access to on-site facilities and equipment
• Database and clinical registry establishment, management and reporting
• Support framework for Investigator-Initiated Research

Organisation Category
Logistics Company

Services
Clinical Trial Management & Logisitics
Dangerous Goods Certificiation Training Course
Logistics
Training

World Courier is the largest and most experienced specialty courier service, with a network of over 140 company-owned ISO 9001-certificed offices, operating in 50 countries worldwide.  World Courier has set the benchmark for worldwide time-sensitive transportation and is the acknowledged leader in delivering customised solutions, cold chain and value-added services in growth markets such as the bio-pharmaceutical industry.
Through its company-owned offices and agents, World Courier provides door-to-door, customs-cleared service to more than 220 countries and territories.

Organisation Category
3D Visualisation and Animation
Digital Communication
Marketing & Communications Company
Multimedia Production

Services
3D Visualisation
Digital Production
Marketing & Communications Services
Product Development Strategy
Product Prototyping and Visualisation
Project Management and Facilitation

3Dme “A Look Inside” uses captivating 3D visualisation technology to take a look inside the human body. With anatomical accuracy and engaging story-telling, we are able to explain technology such as product features and benefits or drug mechanism of action.  3Dme is a specialist 3D visualisation and digital production company with a focus on health and biomedical communications.
We pride ourselves in our ability to comprehend and understand our clients’ sales and marketing objectives, then deliver a product/presentation that will entice, excited and connect with your target audience.
Our expertise is the ability to comprehend a large amount of complex information and transform that into a precise and easily understood, captivating presentation to communicate your message to your client.
Through a unique combination of engaging 3D visualisation and state-of-the-art technology, we are able to help “tell your story” and connect you with your target audience.

Organisation Category
Business Consultancy Organisation

Services
Business Consultancy Services  

biostate provides consulting services to those individuals, institutions and commercial entities who require assistance to identify and realise the commercial potential of their research. With significant experience in the health sector, and as active participants in the biotech and pharmaceutical forums, we can provide:

• advice in identifying the commercial potential of an idea or technology
• assistance in the development of business and marketing plans
• representation for our clients in relevant meetings, conferences or other forums
• guidance in the identification and selection of strategic partners
• support in negotiation of commercial and licensing agreements
• introductions to industry contacts.

read more...

Organisation Category
Corporate Advisory 
Financial Planning
Stockbroking 

Services
Investment consultancy service
Research of listed life science companies

Therapy Area Experience
Devices  
Oncology  
Pain  

The trusted RBS Morgans team of corporate finance professionals are market leaders in all aspects of corporate finance solutions, with a demonstrated track record of delivering outcomes for Australian small and mid-cap companies. Housing a number of world class corporate finance advisers and analysts who specialise in the health care and biotech sector, RBS Morgans has the expertise to guide companies through the capital raising process.

We offer a full range of corporate finance, equity capital markets and advisory services including:

• Initial public offers
• Secondary raisings – placements, rights issues, share purchase plans
• Hybrid and convertible offers
• Share buy backs
• Merger and acquisition advisory – relating to the assessment of acquisitions, mergers, joint ventures and divestment opportunities
• Takeover defence
• Asset / business sales
• Private equity / venture capital

Since the early 1990’s our team at RBS Morgans has structured and raised more than $16.5 billion in new capital for clients in over 950 transactions. We provide our clients with direct access to retail equity markets (through a national stockbroking network), domestic institutional investors (through our dedicated small-mid cap institutional sales team) and international institutional clients (through the Royal Bank of Scotland international network).

read more...

Organisation Category
Manufacturing Facility/Contract Manufacturing Organisation

Services
Bioprocessing/Fermentation  
Contract Manufacturing/Scale-up 
Formulation & Fill 
Process Development 
Tissue Banking 

Therapy Area Experience
Manufacture of a range of therapeutics

BPA has been established with the support of the Queensland Government to achieve two broad objectives:

• To design, fund and implement construction of a biotherapeutic manufacturing facility to be operated in alliance with an experienced international partner
• To support and grow existing local Australian biotherapeutic manufacturing organisations, and to facilitate synergies between complementary providers of clinical development services.
• The new facility with provide a service solution for companies with biological drug candidate who seek to outsource their process development and manufacturing.  It will provide cutting-edge technical and economical methods for generating biopharmaceutical compounds expressed in mammalian cells.

The facility will enable early stage research to be converted into robust, production-ready processes, which can be tested at pilot scale before moving into the highly controlled GMP manufacturing environment required for human medicinal products. BPA will not only cater for pre-clinical development projects, but also for clients manufacturing for clinical trials and the marketplace.

Due to be opened in early 2013, the facility upstream suites will cater for mammalian cell culture up to 2000 litres, with the ability to accommodate future expansion.

Organisation Category
Government – State 
Public Hospital 

Services
Analytical/Pathology Laboratory Services
Clinical Data Management Patient Recruitment
Clinical Monitoring Patient Screening
Clinical Research Treatment of Subjects (Phase III/IV Trials)
Paediatric Clinical Trials 

Therapy Area Experience
Anaesthesilogy 
Cardiology 
Cardiovascular 
Endocrinology 
Gastroenterology 
General Medicine 
Geriatric Medicine  
Obstetrics 
Orthopaedics 
Paediatrics 
Physiotherapy 
Psychiatry 
Radiology
Renal Medicine
Respiratory/Pulmonary
Stroke
Surgery
Urology

General acute outer metropolitan hospital with a busy emergency department, obstetric service, paediatrics, medicine, cardiology, surgery and mental health departments. The Redland Hospital is collocated with a private hospital as well as a residential nursing facility.

Organisation Category
On-line Matching Service

Services
Lab and Consultant Options 
On-line Matching Services

Therapy Area Experience
Allergy
Anti-infectious
Autoimmune Disease
Cardiology
Cardiovascular
CNS/Neurology
Complementary  Medicines
Dermatology
Devices
Endocrinology
Gastroenterology
Genitourinary
Geriatric Medicine
Haematology 
Hypertension
Immunology
Infectious Diseases
Lymphoma
Migraine
Multiple Areas
Multiple Sclerosis
Neurogenetic Disorders
Nutraceutical
Obstetrics
Oncology
Ophthalmology
Orthopaedics
Osteoporosis
Paediatrics
Pain
Pathology
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Rheumatology
Stem Cell Research
Stroke
Surgery
Transplantation
Urology
Vaccines

BioAssayLINK is the ‘Wotif’ or ‘Expedia’ of global therapeutic R&D expertise and capabilities. Our online linking tool connects industry with the expertise and capabilities that they need to advance their new therapeutics. BioAssayLINK is the first convenient online marketplace of biomedical researchers, service providers and specialised consultants. The linking tool provides a rapid, cost effective and customer-specific way for seekers to connect with specialised providers. Seekers submit (and soon search) their laboratory and/or consultant options online. Providers are charged a nominal annual fee to list their specific capabilities and expertise. BioAssayLINK is headquartered in Brisbane, Australia, with distribution networks and affiliates in the United States of America and the United Kingdom and is constantly expanding.

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital)

Services
Clinical Research 
Medical Research 

Therapy Area Experience
Endocrinology 

The Endocrine Clinical Trials Network is based in one of the largest public hospitals in Australia and has been participating in clinical trials since 1986. It has a long history of successful recruitment into clinical trials due to the large patient population that it draws on. Its principal investigator, Dr Michael d’Emden has been on the management committee of several major international trials such as ASPEN, FIELD and TNT. It delivers high quality data and has received high commendations after many major audits. Its major clinical focus is any endocrine study, especially in diabetes and cardiovascular disease prevention trials.
 

Organisation Category
Analytical/Pathology Laboratory 
Central Laboratory 
Clinical Research Organisation 
Contract Research Organisation 
Dedicated Clinical Trials Centre (as part of a public or private hospital
Medical Department
Research Organisation

Services
Clinical Research 
Medical Research 
Pharmacokinetic Analysis 
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience
Allergy  
Anti-infectious  
Cardiovascular  
CNS/Neurology  
Dermatology  
Endocrinology  
Gastroenterology  
Genitourinary  
Haematology
Immunology
Men’s Health
Otolaryngology
Paediatrics
Pain
Psychiatry
Renal Medicine
Respiratory/Pulmonary
Rheumatology
Urology
Vaccines
Volunteers
Women’s Health

AusTrials, a wholly-owned subsidiary of Primary Health Care Ltd, is a leading provider of high-quality clinical research site services in Australia, conducting Phase II to IV studies in a wide range of therapeutic areas.
AusTrials builds on proficiency and expertise gained through the Australian Clinical Research Organisation (ACRO), with over 20 years of successfully conducted studies in over 50 therapeutic areas. The clinical research group has grown to seven cetnre in three states, with over 40 staff.  AusTrials is recognised for prompt study start-up and the highest standards in clinical research data.  AusTrials has also established GP Trial sites in a number of Primary medical centres, with new sites in development. Clinical trial coordinators are engaged on a permanent basis at GP Trials sites, improving recruitment across all Phase II-IV clinical trials.
AusTrials has working relationships with specialists in areas such as Neurology, Cardiology, Respiratory Medicine, Diabetes and Gastroenterology; and is able to communicate with over 1000 General Practitioners in large-scale, well-equipped medical centres throughout most states; with access to Pathology, Radiology, and Health Information technology.

Organisation Category
Biotech Consultancy Organisation 
Business Consultancy Oragnisation 
Government Liaison
Marketing & Communications Company

Services
Biotech Consultancy Services 
Business Consultancy Services 
Commercialisation Services 
Investment Consultancy Services 
Market Research
Marketing & Communications Services

Providing specialist services:
• Government Liaison
• Infrastructure Development Consultant
• Policy Development Advisor
• Networking and Connection Facilitator
• Board Representation
• Corporate Risk Consulting
• Aged Care Consulting Services
• Business Development
 

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital) 
Medical Research Institute 
Not-for-profit Institution/Organisation
Research Institution

Services
Biostatistical Analysis 
Clinical Data Management 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration
Clinical Trial Management & Logistics
Clinical Trial Site Services
Literature Reviews
Medical Research

Therapy Area Experience
Cardio-electrophysiology 
Cardiology 
Cardiovascular
CNS/Neurology
Orthopaedics

St Andrew’s Medical Institute (SAMI) supports clinical trial activities undertaken by the leading medical specialists at St Andrew’s War Memorial Hospital in Brisbane.  These specialists treat a procedural and medical casemix which is among the most acute in Australia, with substantial volume in specific therapeutic areas. SAMI’s collaborative arrangements with St Andrew’s Hospital enable direct access to the technology and facility infrastructure to support these activities.

Organisation Category
Analytical/Pathology Laboratory 
Biomarker Discovery 
Dedicated Clinical Trials Centre (as part of a public or private hospital)
Medical Research Institute 
Not-for-profit Institution/Organisation 
Preclinical Facility
Research Institution
Research Organisation

Services
Analytical/Pathology Laboratory Services
Bioassays 
Bioinformatics 
Biomarkers Discovery 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration 
Contract Research Services 
Genomics Research 
Medical Research 
Nutraceutical
Patient Recruitment
Pharmacogenomics
Preclinical Research
Tissue Banking
Translational Medicine
Treatment of Subjects (Phase 0 Trials)
Treatment of Subjects (Phase I/II Trials)
Treatment of Subjects (Phase III/IV Trials)

Therapy Area Experience
Endocrinology 
Men’s Health 
Nutraceutical 
Oncology  
Pathology 
Surgery 
Urology

The Australian Prostate Cancer Research Centre – Queensland is a transdisciplinary research centre focussed on the development of prostate cancer therapeutics and prognostic biomarkers. Hosted by the Queensland University of Technology at the Princess Alexandra Hospital, the APCRC-Q’s activities span from high throughput discovery, molecular pathology and functional characterisation of potential targets, through to preclinical therapeutic development and evaluation and clinical trials. The APCRC-Q is underpinning the establishment of a multi-disciplinary prostate cancer clinical trials unit at the Princess Alexandra Hospital for Phase I/II and III trials.

The prostate cancer clinical trials unit will work in close association with the Australia New Zealand Urogenital and Prostate Cancer Clinical trials consortium and the Trans-Tasman Radiation Oncology Group, as well as the international prostate cancer-focussed clinical trials consortia.  The APCRC-Q is the Australian hub of the Australian-Canadian Prostate Cancer Research Alliance Program.  This international network partners more than 250 scientists, clinicians, and other professionals working in prostate cancer, in order to facilitate access to unique resources, leading edge infrastructure, and clinical trials networks. The Australian Prostate Cancer Research Centre – Queensland is highly interested in working collaboratively or contracting with biotech, pharma and other industries in the development of new therapeutics, imaging and biomarkers.

Organisation Category
Medical Cooperative Group 
Not-for-Profit Public Benevolent Institution

Services
Clinical Trial Administration  
Ethics Committee 
Protocol Review & Amendment Service
Ethics Committee Expedited Access for Submissions

Therapy Area Experience
Oncology 
Radiology 
Respiratory/Pulmonary  
Transplantation 
Vaccines
Volunteers 

The Australian Lung Foundation’s Multi-Centre Clinical Trials Network (ALF MCTN) is an established service available to clinical trial sponsors and Clinical Research Organisations (CROs).  It provides access to a large-scale investigator and patient database.  The MCTN is supported by an efficient ethics submission process as well as an established network and recruitment management system.
The Network has been formed to support both local and international studies. It does not compete with the institutions that currently undertake clinical trials, but will enhance the recruitment base so that collectively, recruitment targets and tight study timelines can be met.  The ALF MCTN business returns any surplus earned to the ALF assisting the Foundation to fulfill their vision as a key agent of change in Australia, bringing about the understanding, management and relief of lung disease.

Organisation Category
Analytical/Pathology Laboratory 
Central Laboratory

Services
Analytical/Pathology Laboratory Services
Clinical Trial Management & Logistics 
Logistics 

Therapy Area Experience
All areas   

Sullivan Nicolaides Pathology has considerable experience in the provision of clinical trial services to the pharmaceutical industry and university research departments.
Logistics: Whilst utilising the extensive coverage of our own courier network, Sullivan Nicolaides Pathology also works in close co-operation with major courier companies to supply investigator sites with supplies, and rapid pick-up and return of samples for testing.
Rapid Result Turnaround: Sullivan Nicolaides Pathology provides services 24 hours a day, 7 days a week.  All samples are processed immediately on arrival with most reports being returned to the investigator site within 24 hours by transmission medium of your choice.
Supplies and Documentation: Collection supplies can be supplied as visit-specific kits or in ‘bulk.’ Request forms are study and site specific. Comprehensive, easy to use laboratory manuals are provided for each investigator site to ensure good site compliance.
Trials Management: Sullivan Nicolaides Pathology has dedicated in-house staff assigned to assist investigators in providing the samples required and to ensure that all requisitions are complete.
 

Organisation Category
Analytical/Pathology Laboratory 
Bioanalytical Facility 
Contract Research Organisation
Preclinical Facility

Services
Analytical/Pathology Laboratory Services 
Bioassays 
Efficacy- in-vitro and in-vivo models of efficacy 
Toxicology: in-vitro and in-vivo, genotoxicity assays, dose-range finding studies
Pharmaceutics: characterisation, stability, formulation development, dissolution
Pharmacokinetic Analysis
Pharmaceuticals & Toxicology
Translational Medicine

Therapy Area Experience
Allergy  
Anaesthesiology 
Autoimmune Disease 
Cardiovascular  
CNS/Neurology 
Complementary Medicines 
Dermatology
Endocrinology 
Gastroenterology 
Multiple Sclerosis
Nutraceutical 
Paediatrics 
Pain
Psychiatry
Respiratory/Pulmonary
Rheumatology
Vaccines

TetraQ is Australia’s leading, fully-integrated preclinical drug development contract research organisation (CRO) providing a range of high-quality, integrated and tailored preclinical services (ADME, Efficacy, Pharmaceutics, Toxicology) globally to pharmaceutical and biotechnology industries.  TetraQ has NATA ISO 17025 (R&D) accreditation and GLP recognition which allows bioanalytical and toxicology work to be accepted internationally for regulatory review and provides a high degree of assurance for TetraQ clients.
TetraQ work with companies developing new drugs, seeking assistance with selecting a drug candidate or requiring preclinical drug characterisation. TetraQ develop preclinical programs to ensure careful selection of studies which is critical to save on time and expenditure.
TetraQ aims to provide a ‘one-stop’ service and advice for clients. TetraQ has world-class facilities backed by a highly-skilled scientific team with a wealth of experience in all four core disciplines of preclinical development. The TetraQ team take the time to understand your business needs and provide comprehensive tailored solutions either in-house or through their extensive network. In addition to providing a range of contract services, TetraQ can also:
• Consult to your business by providing expert opinions, reviewing and interpreting data, reviewing and preparing product development plans and assisting in due diligence.
• Advise on early-stage drug development activities including regulatory strategy.
TetraQ currently provide services to clients base in the United States of America, Japan, Europe, the United Kingdom, SE Asia and New Zealand.

Organisation Category
Commercialisation Company

Services
Commercialisation Project Management Services
Market Research and Opportunity Analysis
Professional Development Programs to increase Commercialisation skills and successes
Strategic Advice around Intellectual Property Management and Commercialisation
Technology Transfer Facilitation and brokerage of Intellectual Property (IP)

The Australian Institute for Commercialisation (AIC) is a leading service organisation helping innovators achieve commercial success. Around Australia, the AIC helps business, research organisations and governments convert their ideas into successful outcomes.
Using our networks and experience, we deliver services that facilitate collaboration, enhance innovation and accelerate the commercialisation of know-how and technology that our clients have created.
By providing advice, solutions and tools, and through our intermediary services, we fast-track the commercialisation of Australian innovation.
Clients working with the AIC are able to better develop their ideas and capitalise on opportunities that create high value jobs, exports and wealth.
 

Organisation Category
Research Institution 

Services
Bioassays 
Bioprocessing/Fermentation 
Commercialisation Services 
Contract Research Services Diagnostic Development & Delivery 
Drug Delivery
Drug Discovery
Preclinical Research
Training

The University of Queensland’s Australian Institute for Bioengineering and Nanotechnology (AIBN) is an integrated multi-disciplinary research institute bringing together the skills of world-class researchers in the areas of bioengineering and nanotechnology.
It is home to 18 research groups working at the interface of the biological, chemical and physical science to alleviate current problems in human health and environmental issues.
The Institute has three key areas that collectively distinguish it from other institutes in the country, namely AIBN’s:
• Research Excellence;
• Industry Focus; and
• Dynamic Research Environment

These characteristics focus AIBN research efforts on developing new products, processes and devices for improving human health and quality of life. In this way the Institute goes beyond basic research to promote and develop the growth of innovative industries, which will benefit the Queensland and Australian economies.
 

Organisation Category
Clinical Research Organisation 
Clinical Trials Unit

Services
Clinical Research  
Clinical Research Network Contract Research Services 
Medical Research
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience
Allergy
Anti-infectious
Cardiovascular
CNS/Neurology
Complementary Medicines
Devices
Endocrinology
Gastroenterology
General Medicine
Genitourinary
Geriatric Medicine
Hypertension
Immunology
Infectious Diseases
Men’s Health
Migraine
Multiple Areas
Nutraceutical
Osteoporosis
Paediatrics
Pain
Respiratory/Pulmonary
Vaccines
Volunteers
Women’s Health

Trialworks is a community-based clinical trials centre with access to a large GP network and healthy volunteers.  The PI has had 15 years experience in Phase II-IV clinical trials and outcomes-based studies across a wide range of indications in both public and private settings.  Trials have been conducted for all the major pharmaceutical companies, CROs and University-based research centres. The centre is staffed by highly experienced research nurses/trial coordinators who have been working with the PI for more than nine years. Trialworks works closely with both public and private institutions to ensure the successful conduct and completion of its contracted trials.

Organisation Category
Contract Research Organisation 
Genomics Service Provider to Academic and Industrial Markets
Not-for-profit Institution/Organisation

Services
Bioinformatics 
Clinical Research
Contract Genomics Services 
Genomics Research  
Medical Research
Pharmacogenetics
Pharmacogenomics
Provision of Genomics Services to industrial customers for applied applications such as Microbial Identification, quality screening as part of biopharmaceutical production
Quality Assurance

Australian Genome Research Facility Ltd (AGRF) was established in 1997 with the mission of providing high quality genomic services to the academic and industrial markets spanning biomedicine, plant and animal science, microbiology, evolutionary biology and biodiversity.
With facilities in Brisbane, Melbourne, Adelaide and Sydney, AGRF Ltd is Australia’s largest genomics service provider. We place a high valued on quality and maintain accreditation to the internationally recognised ISO 17025:2005 quality standard as well as other regulatory licences. The AGRF Brisbane Node houses AGRF’s Sanger and Next-Generation sequencing services as well as the Sequenom SNP Genotyping platforms. AGRF’s services range from pharmacogenomics, small to large-scale DNA sequencing using Sanger and Next-Generation technologies, genotyping/SNP analysis, gene expression studies and small to large scale nucleic acid extractions. Our services are underpinned by the provision of customised bioinformatics solutions.
 

Organisation Category
Not-for-profit institution/organisation

Services
Business Consultancy Services

TropLinks Inc. is the engine that will power the research, development and export of Australia’s tropical expertise to the world.  Its primary goal is to develop a globally competitive tropical economy by establishing Australia as a world leader in tropical science, knowledge and innovation.
As a not-for-profit incorporated association, TropLinks Inc. is a network of research bodies, companies, industry groups and economic development organisations that are working together to build the critical mass needed to capture a slice of the global tropical market.  Within the network, members maintain their own corporate identity and benefit from the synergy of association and complementary skill sets that TropLinks Inc. offers.
TropLinks Inc. provides the branding, support and vision that members need to expand their tropical reach without sacrificing corporate identity or IP ownership. It provides the following services to members:
• Funding and capital raising – actively identifying funding pools and attracting investment for projects and industry development.
• Business matching – bringing members together to bid collaboratively for major projects.
• Identity and branding – creating a united, internationally-recognised presence to make it easier for members to market products and services.  TropLinks Inc. will also focus on establishing a defined industry sector in tropical expertise.
• Stakeholder engagement – networking members and building the critical mass to grow a sophisticated tropical expertise industry.
• Corporate leadership – lobbying, coordinating and securing strategic opportunities for members.

Organisation Category
Biotech Company 

Services
Companion Diagnostics 
Continuous Patient Monitoring 
Molecular Diagnostics
Personalised Medicine
Theranostics

Therapy Area Experience
Devices   
Emergency     
Immunology
Infectious Diseases
Intensive Care
Oncology
Sepsis

Organisation Description

Athlomics’ business is the personalised management of sepsis patients. The incidence of sepsis and septic shock is rising, now affecting younger patients. With a mortality rate of almost 30%, sepsis is the most common non-coronary cause of death in Intensive Care Units.  All-cause sepsis affects 750,000 US hospitalisations yearly and more than half of these are estimated to be hospital-acquired. Sepsis affects 5 to 10% of all hospital patients, leading to an increase of about US$5bn in US health care costs annually. The Total annual cost of sepsis to the US healthcare system is ~US$16bn. Globally, there are an estimate 18 million cases of sepsis per year.

Athlomics’ SeptiCyte® molecular technology can be used for:
1. Earlier detection (<3hrs) and more specific diagnosis of sepsis (85 to 95%; p<0.01), and
2. Regular patient monitoring of
• Sepsis patients in Intensive Care Units (ICU) (immune system response to therapy), and
• Immuno-compromoised patients, e.g. chemotherapy, transplant, AIDS, long-term steroid use, young and the elderly (earlier detection and potential prevention)

Athlomics will launch its first early diagnostic product in Australia in Q2 2010 through Mater Pathology, a wholly-owned business unit of Mater Misericodiae Health Services Brisbane Ltd, Australia.
It has two longitudinal trials underway at Australian hospitals where clinical efficacy is being further evaluated in the regular monitoring of two patient groups:
1. Patients diagnosed with sever sepsis (+ve micro) to monitor the patient’s immune response to therapy, and
2. Patients on chemotherapy (compromised immune system) to monitor for the earlier detection of sepsis.

Athlomics has currently fulfilled Australian regulatory requirements as an LDT.  In the US, the early diagnostic will likely be deemed and In Vitro Diagnostic Mulitvariate Index Assay (IVDMIA) – either Class II or III risk.

Organisation Category
Clinical Trials Unit 
Medical Research Institute 
Not-for-profit Institution/Organisation

Services
Biomarkers Discovery 
Clinical Research 
Clinical Research Network 
Medical Research 
Patient Recruitment 
Preclinical Research 
Tissue Banking
Translational Medicine
Treatment of Subjects (Context of Phase 0 Trials)
Treatment of Subjects (Context of Phase I/II Trials)
Treatment of Subjects (Context of Phase III/IV Trials)

Therapy Area Experience
Anti-infectious
Cardio-electrophysiology
Cardiovascular
CNS/Neurology
Dermatology
Genitourinary
Infectious Diseases
Intensive Care
Men's Health
Multiple Sclerosis
Neurogenetic Disorders
Nutraceutical
Obstetrics
Paediatrics
Pathology
Physiotherapy
Psychiatry
Radiology
Renal Medicine
Rheumatology
Stem Cell Research
Stroke
Urology
Women's Health

Organisation Description
The University of Queensland’s Centre for Clinical Research (UQCCR) is a new $66M facility designed to bridge the gap between exponentially-expanding biomedical science and the increasing complexity of modern patient care. Our joint ‘bench to bedside’ and ‘bedside to bench’ focus addresses a critical area of unmet need in the early 21st century. UQCCR offers a unique and exciting opportunity for new and established investigations to pursue cutting-edge, clinically-relevant research in a world-class facility.  UQCCR is pivotally located alongside Australia’s largest 1,000 bed tertiary Royal Brisbane & Women’s Hospital (RBWH). UQCCR’s 8,000m2 building boasts state-of-the-art equipment, 1 clinical research floor with outpatient facility for up to 500 patients/day, and 5 wet laboratory floors. Our goals are to foster innovation in clinical research; translate basic and applied research into more effective outcomes for patients; and train tomorrow’s generation of translational researchers and MD PhD Clinical Scientists.

 

Organisation Category
Clinical Research Organisation 
Complementary/Nutraceutical Company 
Contract Research Organisation 
Regulatory Consultancy
Research Organisation

Services
Clinical Monitoring 
Clinical Project Management 
Clinical Research 
Clinical Trial Administration 
Contract Research Services 
Literature Reviews  
Nutraceutical 
Patient Screening
Product Development Strategy
Product Listing & Registration
Protocol Review & Amendment Services
Regulatory Consultancy
Training
Treatment of Subjects (Context of III/IV Trials)

Therapy Area Experience
Complementary Medicines   
Nutraceutical   

Applied Science and Nutrition Pty Ltd (ASN) is an independent Contract Research Organisation specialising in complementary medicine and nutraceutical product research.  We partner closely with our clients to help them develop their ‘ideas’ into successful globally-marketed complementary medicines.  Our primary focus is the design and management of all stages of clinical trials.
ASN comprises a team of regarded specialist complementary medicine researchers that are driven to advance the valid evidence-base for complementary medicines within the broader healthcare context. In collaboration with general practitioners, clinicians and leading service providers, we are uniquely positioned to provide quality complementary medicine research.  Our extensive regulatory knowledge and understanding of the challenges unique to complementary medicine research ensures we are able to design and manage trials that support clients’ product-realisation efforts.

Organisation Category
Biotech Consultancy Organisation 
Business Consultancy Organisation 

Services
Biotech Consultancy Services 
Business Cases for R&D Funding 
Business Consultancy Services 
Commercialisation Services
Investment Consultancy Services
Medical Writing

Therapy Area Experience
Anti-infectious   
Autoimmune Disease  
Cardiology  
Complementary Medicines  
Devices
Infectious Diseases
Nutraceutical
Obstetrics
Oncology
Ophthalmology
Orthopaedics

VenturePro is a professional services firm that specialises in developing and assessing business plans and grant applications for public and private organisations. We have expertise in co-ordinating the development of research project plans, writing business cases for major R&D funding and preparing business plans.  Since 2005, VenturePro clients have been awarded over $280m in government and private funding for R&D projects.  The success rate across all of our clients is 82% with the median grant being $2.0m, and the average being $6.4m. We contribute to science and innovation policy through the development of major life sciences industry analyses including the 2007 and 2009 Queensland Life Sciences Industry Reports. Our clients include universities across Australia including 7 of the G8 Universities, the ATN universities and many others. Some of our health sector clients in Queensland include the Royal Brisbane and Women’s Hospital, Greenslopes Private Hospital, St Andrew’s Medical Research Institute, the Hear and Say Centre, Queensland Brain Institute, TetraQ, QUT Institute of Health and Biomedical Innovation, Queensland Institute of Medical Research, Queensland Tropical Health Alliance, Australian Institute for Bioengineering and Nanotechnology and several biotechnology and medical device companies.

Organisation Category
Business Consultancy Organisation

Services
Biostatistical Analysis 
PGx data interpretation 
PGx reporting and compliance
Pharmacogenomics

Organisation Description
ACTG possesses a unique capability in integrating leading edge molecular, statistical and IT skills across the spectrum of pharmacogenetic/pharmacogenomic activities. It provides these capabilities through:

1. Microarray Design
• Design and content of PGx-specific microarrays
• Detailed technical knowledge of genomic and genetic platforms, including proven experience of the quality control and statistical process control procedures required to manage genetic and genomic data to highest world standards.

2. Study Setup
• Sophisticated experimental design capability, ranging from individual study design through to development and optimization of marker discovery strategy.

3. Study Infrastructure
• Development, management and integration of FDA-compliant information systems for clinical and laboratory data.
• Implementation of fully compliant standard operating procedures and processes, to ensure delivery of high quality data with maximum operating efficiency.

4. Study Execution and Analysis
• Expert biostatistics and bioinformatics linking clinical outcomes to genomics and genetic markers
• Sophisticated analysis of large-scale pharmacogenetic data, with current capability embracing hundreds of thousands of SNPs on hundreds of thousands of patients.

Organisation Category
Business Consultancy Organisation

Services
Business Consultancy Services

Organisation Description
The Principal and Founder of Vicibio, Dr Peter Riddles, has broad experience in science and innovation having contributed to both government and private sector activities in the life sciences industries in Australia and elsewhere.
Vicibio facilitiates strategic planning in organisations where science, technology and innovation are vital to the business activities.
Key clients include governments, public sector research agencies and private sector new ventures. During the facilitation, Vicibio will consider innovation, governance, policy and strategy.
If required, Vicibio will assist the organisation in attracting boards and financing.

Vicibio provides the following core capabilities and experiences:
• Knowledge of innovation policy and strategy
• Experienced Entrepreneur and Director of new ventures
• Experienced Chairman of government and private sector organisation including complex multi-stakeholder ventures
• The ability to conceptualise and develop scoping studies with complex technical and market opportunities
• Experienced at reviewing and evaluating programs in both government and private sector
• Expertise in science and technology and its commercialisation.

The principal of Vicibio, Dr Peter Riddles, may be retained in the longer term as a Chairman/Director or as a strategic advisor, or engaged on a project basis.

Organisation Category
Clinical Research Organisation 
Clinical Trials Unit 
Medical Cooperative Group 
Not-for-profit Institution/Organisation
Research Organisation
Tissue Bank

Services
Bioinformatics 
Clinical Research 
Clinical Research Network 
Clinical Trial Administration 
Contract Research Services 
Tissue Banking
Training
Translational Medicine
Treatment of Subjects (Phase I/II)
Treatment of Subjects (Phase III/IV)

Therapy Area Experience
Genitourinary  
Men’s Health  
Oncology  
Pathology
Psychiatry
Renal Medicine
Urogenital
Urology
Women’s Health

ANZUP is The Australian and New Zealand Urogenital and Prostate Cancer Trials Group funded by Cancer Australia to develop and conduct cancer research in Urogenital and Prostate Cancers. The group fosters collaboration between researchers by aiming to minimise the effect of prostate and other urogenital cancers on the community in terms of survival, incidence and quality of life, through research and education and by providing patients and carers with support and will conduct and promote cooperative clinical trials and psychosocial research and prostate and other urogenital cancers.

The object of the company is to develop, foster and promote prostate and urogenital cancer research by:
• Providing access to clinical trials for all appropriate Australian and New Zealand patients
• Increasing involvement of and collaboration with various professional disciplines in clinical and preclinical research
• Building systems to simplify and streamline clinical research of the highest quality
• Fostering a culture of research amongst all clinicians involved in the care of patients with urogenital cancers
• Providing training opportunities for the next generation of clinical researchers
• Providing for translational studies in prostate and other urogenital cancers, including tissue banking from clinical trials for further studies

Organisation Category
Dedicated Clinical Trials Centre (as part of a public or private hospital) 
Medical Research Institute 
Research Institution 
Study Management Organisation
Tissue Bank

Services
Clinical Data Management  
Clinical Monitoring  
Clinical Project Management  
Clinical Research  
Clinical Trial Administration  
Clinical Trial Management & Logistics   
Clinical Trial Site Services
Patient Recruitment
Patient Screening
Project Management Services
Tissue Banking
Translational Medicine
Treatment of Subjects (Phase I/II Trials)
Treatment of Subjects (Phase III/IV Trials)

Therapy Area Experience
Anti-Infectious
Auto-Immune Disease
Cardiovascular
Dermatology
Devices
Endocrinology
Gastroenterology
Gynaecology
Haematology
Healthy Volunteers
Immunology
Intensive Care
Men’s Health
Neurology
Nutraceuticals
Oncology
Pain Management
Psychiatry
Renal Medicine
Rheumatology
Surgery
Urology
Vaccines
Women’s Health

The Wesley Research Institute (WRI), established in 1994, is an independent not-for-profit medical research facility  that provides support for laboratory, clinical and translational research that works towards its shared value of ‘making a difference today.’ The Institute incorporates Queensland’s largest Tissue Bank, an innovative Health and Medical Research Centre and the Clinical Trials Centre. WRI has strong affiliations with world class, research-focused universities and other medical institutes.
The Clinical Trials Centre has an established base of specialist investigators, access to a general practitioner referral network and private hospital services which provides our clients with wide-ranging clinical expertise and a comprehensive, high-quality service which includes:
• Conduct of clinical trials from Phase I-IV (including device and surgical) over a diverse range of therapeutic specialties
• Single point of contact to coordinate single and multi-centre trials
• Timely and cost-effective submission of protocols to the on-site Human Research Ethics Committee
• Efficient financial and contract administration processes
• Specimen collection and management including access to on-site facilities and equipment
• Investigational Product storage & dispensing including access to on-site facilities and equipment
• Database and clinical registry establishment, management and reporting
• Support framework for Investigator-Initiated Research

Organisation Category
Logistics Company

Services
Clinical Trial Management & Logisitics
Dangerous Goods Certificiation Training Course
Logistics
Training

World Courier is the largest and most experienced specialty courier service, with a network of over 140 company-owned ISO 9001-certificed offices, operating in 50 countries worldwide.  World Courier has set the benchmark for worldwide time-sensitive transportation and is the acknowledged leader in delivering customised solutions, cold chain and value-added services in growth markets such as the bio-pharmaceutical industry.
Through its company-owned offices and agents, World Courier provides door-to-door, customs-cleared service to more than 220 countries and territories.

Organisation Category
3D Visualisation and Animation
Digital Communication
Marketing & Communications Company
Multimedia Production

Services
3D Visualisation
Digital Production
Marketing & Communications Services
Product Development Strategy
Product Prototyping and Visualisation
Project Management and Facilitation

3Dme “A Look Inside” uses captivating 3D visualisation technology to take a look inside the human body. With anatomical accuracy and engaging story-telling, we are able to explain technology such as product features and benefits or drug mechanism of action.  3Dme is a specialist 3D visualisation and digital production company with a focus on health and biomedical communications.
We pride ourselves in our ability to comprehend and understand our clients’ sales and marketing objectives, then deliver a product/presentation that will entice, excited and connect with your target audience.
Our expertise is the ability to comprehend a large amount of complex information and transform that into a precise and easily understood, captivating presentation to communicate your message to your client.
Through a unique combination of engaging 3D visualisation and state-of-the-art technology, we are able to help “tell your story” and connect you with your target audience.